CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China · Delayed Price · Currency is CNY 30.37
+0.43 (1.44%)
Apr 30, 2026, 3:07 PM CST
SHE:300765 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -308.08 | -241.13 | 53.73 | 434.44 | 726.28 | 393.23 |
Depreciation & Amortization | 223.15 | 223.15 | 217.33 | 155.56 | 72.94 | 69.15 |
Other Amortization | 0.08 | 0.08 | - | - | - | - |
Loss (Gain) From Sale of Assets | -2.78 | -2.78 | -0.55 | - | 4.61 | - |
Asset Writedown & Restructuring Costs | 3.66 | 3.66 | 2.94 | 1.82 | - | 13.19 |
Loss (Gain) From Sale of Investments | 17.57 | 17.57 | 0.89 | -12.58 | -16.82 | -21.31 |
Provision & Write-off of Bad Debts | 8.01 | 8.01 | -2.95 | -4.85 | 7.8 | 6.03 |
Other Operating Activities | -398.06 | -372.29 | -361.62 | -305.12 | -54.64 | 9.16 |
Change in Accounts Receivable | -203.08 | -203.08 | 253.91 | 224.79 | -224.89 | -119.21 |
Change in Inventory | -102.41 | -102.41 | -176.63 | -9.17 | -24.82 | -113.85 |
Change in Accounts Payable | 473.24 | 473.24 | -1,219 | 1,081 | 157.24 | 56.71 |
Change in Other Net Operating Assets | - | - | - | -845.85 | - | - |
Operating Cash Flow | -288.41 | -195.69 | -1,235 | 721.14 | 640.72 | 292.09 |
Operating Cash Flow Growth | - | - | - | 12.55% | 119.36% | -16.32% |
Capital Expenditures | -579.69 | -568.39 | -477.78 | -581.42 | -114.05 | -195.41 |
Sale of Property, Plant & Equipment | 9.02 | 9.02 | 3.81 | 11.24 | 5.82 | 2.3 |
Cash Acquisitions | -29 | -29 | - | - | - | - |
Divestitures | - | - | - | - | - | 118.79 |
Investment in Securities | -185 | 235 | -820 | -1 | 416.52 | -88.46 |
Other Investing Activities | 14.12 | 14.85 | 2.53 | - | 3.59 | 7.43 |
Investing Cash Flow | -770.55 | -338.51 | -1,291 | -571.18 | 311.88 | -155.36 |
Short-Term Debt Issued | - | 3.2 | - | - | - | - |
Long-Term Debt Issued | - | - | - | - | 20 | - |
Total Debt Issued | 13.2 | 3.2 | - | - | 20 | - |
Long-Term Debt Repaid | - | -0.86 | -1.57 | -20.86 | -0.86 | -0.86 |
Total Debt Repaid | -0.86 | -0.86 | -1.57 | -20.86 | -0.86 | -0.86 |
Net Debt Issued (Repaid) | 12.34 | 2.34 | -1.57 | -20.86 | 19.14 | -0.86 |
Issuance of Common Stock | - | - | - | 1,989 | - | - |
Repurchase of Common Stock | - | - | -316.78 | -4.25 | -0.07 | - |
Common Dividends Paid | -36.43 | -36.43 | -374.16 | -97.85 | -82.07 | -42 |
Other Financing Activities | 395.75 | 458.28 | 300 | -480.01 | - | - |
Financing Cash Flow | 371.66 | 424.19 | -392.51 | 1,386 | -63.01 | -42.86 |
Foreign Exchange Rate Adjustments | 14.18 | 20.27 | 7.8 | 30.82 | 57.55 | -6.88 |
Net Cash Flow | -673.12 | -89.75 | -2,911 | 1,567 | 947.14 | 86.98 |
Free Cash Flow | -868.11 | -764.08 | -1,713 | 139.72 | 526.67 | 96.67 |
Free Cash Flow Growth | - | - | - | -73.47% | 444.79% | -58.21% |
Free Cash Flow Margin | -36.94% | -35.41% | -86.47% | 5.50% | 20.05% | 5.23% |
Free Cash Flow Per Share | -0.62 | -0.55 | -1.22 | 0.10 | 0.39 | 0.07 |
Cash Income Tax Paid | 62.29 | 69.76 | 118.12 | 5.46 | 93.04 | 108.71 |
Levered Free Cash Flow | 175.48 | 139.27 | -1,164 | 1,127 | 434.79 | -59.54 |
Unlevered Free Cash Flow | 195.43 | 152.91 | -1,160 | 1,138 | 434.92 | -57.76 |
Change in Working Capital | 168.04 | 168.04 | -1,145 | 451.86 | -99.45 | -177.36 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.